Pfizer (PFE) Exchange Rate Effect (2009 - 2026)

Pfizer has disclosed Exchange Rate Effect across 18 years of filings, most recently posting $19.0 million for Q1 2026.

• In Q1 2026, Exchange Rate Effect rose 371.43% year-over-year to $19.0 million; the TTM figure through Mar 2026 stood at $67.0 million (up 174.44% YoY), while the FY2025 annual figure was $41.0 million, up 162.12% from the prior year.
• Exchange Rate Effect climbed to $19.0 million in Q1 2026, from $5.0 million in the prior quarter.
• Over the last five years, Exchange Rate Effect for PFE reached as high as $41.0 million in Q2 2025 and fell as low as -$139.0 million in Q4 2022.
• The 5-year median for Exchange Rate Effect is -$5.0 million (2023), against an average of -$17.9 million.
• Annual changes were most pronounced in 2022 — Exchange Rate Effect slumped 1420.0% — and 2026, when it jumped 371.43%.
• A 5-year view of Exchange Rate Effect shows it stood at -$139.0 million in 2022, then surged by 99.28% to -$1.0 million in 2023, then tumbled by 3600.0% to -$37.0 million in 2024, then soared by 113.51% to $5.0 million in 2025, then jumped by 280.0% to $19.0 million in 2026.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered $19.0 million, $5.0 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.